Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol
CA 2425310 A1 · Owner: Stephenne, Jean · Inventors: Gerard, Catherine Marie Ghislaine; Stephenne, Jean; Garcon, Nathalie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to novel adjuvant compositions for use in vaccines. In particular, the adjuvant compositions of the present invention comprise a combination of an immunostimulatory oligonucleotide and a tocol. Also provided by the present invention are vaccines comprising the adjuvant compositions of the present invention and at least one antigen. Further provided are methods of manufacture of the adjuvant compositions and vaccines of the present invention and their us as medicaments. Additionally the , present invention provides methods of treating an individual susceptible to or suffering from a disease by the parenteral or mucosal administration of the vaccines of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 16, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 16, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 16, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.